
William Blair News
Keep up to date on our recent transactions, announcements, and events.

News and Events
-
Zentalis Pharmaceuticals, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Zentalis Pharmaceuticals, Inc. (ZNTL $3.50), a clinical-stage biotech company focused on developing azenosertib, a small-molecule WEE1 inhibitor, for the treatment of ovarian cancer and other tumors.
-
The Metals Royalty Company Inc.: Initiation of Research Coverage
William Blair initiated research coverage of The Metals Royalty Company Inc. (TMCR $5.41). The Metals Royalty Company is focused on acquiring critical metals and energy royalty interests that support U.S. mineral security, with key royalties in the NORI and Mesabi projects.
-
Lyntris Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Lyntris Inc. (LYNX $12.39), a supplier of mission-critical radio frequency, sensor, and software technologies enabling connectivity across air and missile defense, maritime awareness, and space-based missions.
-
-
-
-
Awards and Recognition
-

William Blair Recognized Among Massachusetts’ Most Charitable Companies for Sixth Consecutive Year
William Blair has once again been named one of Massachusetts’ Most Charitable Companies by the Boston Business Journal, marking the sixth consecutive year the firm has received its Corporate Citizenship Award.
-

-

-

-

-

In The Media
-
-
-
Josh Walshe Featured on Citywire Pro Buyer Podcast
Josh Walshe, director, investment research & solutions for William Blair’s consulting services team, was the featured guest on Citywire Pro Buyer’s “PB Pod!” podcast, where he discussed the latest innovations in ETFs and diversification in the AI age.
-
-
Contact Us
Please contact Padraic Swanton with any media-related inquiries or to request a complete media kit.
+1 312 364 5290
pswanton@williamblair.com
For inquiries related to Equity Research, please contact Chris Thonis.
+1 312 364 8565
cthonis@williamblair.com
Delivered to Your Inbox
Stay up-to-date with the latest William Blair news and insights

